Single-Session Bronchial Thermoplasty Guided by 129Xe Magnetic Resonance Imaging: A Pilot Randomized Clinical Trial.

RATIONALE Adverse events have limited the use of bronchial thermoplasty (BT) in severe asthma. OBJECTIVES We sought to evaluate the effectiveness and safety of using 129Xe MRI to prioritize the most involved airways for guided BT. METHODS Thirty subjects with severe asthma were imaged with volumetric CT and 129Xe MRI to quantitate segmental ventilation defects. Subjects were randomized to treatment of the six most involved airways in the first session (guided group) or a standard three-session BT (unguided). The primary outcome was the change in Asthma Quality of Life Questionnaire (AQLQ) score from baseline after the first BT for the guided group compared to after three treatments for the unguided group. MEASUREMENTS AND MAIN RESULTS There was no significant difference in quality of life after one guided compared to three unguided BTs (ΔAQLQ guided= 0.91[95% CI, 0.28 to 1.53], unguided=1.49 [95% CI, 0.84 to 2.14] P=0.201). After one BT, the guided group had a greater reduction in the percent of poorly/non-ventilated lung from baseline when compared to unguided (-17.2%, P=0.009). At one year, both AQLQ and asthma control tests (ACT) improved from baseline (ΔAQLQ=1.50±1.63 P=<0.001, ΔACT=5.61±5.24 P<0.001) and there was no significant difference between groups. Thirty-three percent experienced asthma exacerbations after one guided BT compared to 73% after three unguided BT (P=0.028). CONCLUSION Results of this pilot study suggest that similar short-term improvements with improved safety can be achieved with one BT treatment guided by 129Xe MRI when compared to standard BT.

[1]  G. Donovan,et al.  Patient-specific targeted bronchial thermoplasty: predictions of improved outcomes with structure-guided treatment. , 2019, Journal of applied physiology.

[2]  G. Parraga,et al.  Optimizing sputum cell counts prior to bronchial thermoplasty: A preliminary report , 2019, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine.

[3]  L. Boulet,et al.  Persistent Reduction of Mucin Production after Bronchial Thermoplasty in Severe Asthma. , 2019, American journal of respiratory and critical care medicine.

[4]  J. Krings,et al.  Role of Biologics in Asthma , 2019, American journal of respiratory and critical care medicine.

[5]  G. Donovan,et al.  Unraveling a Clinical Paradox: Why Does Bronchial Thermoplasty Work in Asthma? , 2018, American journal of respiratory cell and molecular biology.

[6]  I. Pavord,et al.  Dupilumab Efficacy and Safety in Moderate‐to‐Severe Uncontrolled Asthma , 2018, The New England journal of medicine.

[7]  G. Parraga,et al.  Sputum Eosinophilia and Magnetic Resonance Imaging Ventilation Heterogeneity in Severe Asthma , 2018, American journal of respiratory and critical care medicine.

[8]  Stanley J Kruger,et al.  Ventilation defect percent in helium-3 magnetic resonance imaging as a biomarker of severe outcomes in asthma. , 2017, The Journal of allergy and clinical immunology.

[9]  D. Fielding,et al.  Bronchial thermoplasty: activations predict response , 2017, Respiratory Research.

[10]  J. Clancy,et al.  Hyperpolarized 129Xe for investigation of mild cystic fibrosis lung disease in pediatric patients. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[11]  Rohan S. Virgincar,et al.  Hyperpolarized 129Xenon Magnetic Resonance Imaging to Quantify Regional Ventilation Differences in Mild to Moderate Asthma: A Prospective Comparison Between Semiautomated Ventilation Defect Percentage Calculation and Pulmonary Function Tests , 2017, Investigative radiology.

[12]  Mario Castro,et al.  Using imaging as a biomarker for asthma , 2017, The Journal of allergy and clinical immunology.

[13]  W. Busse,et al.  Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial , 2016, The Lancet.

[14]  David Couper,et al.  SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. , 2016, American journal of respiratory and critical care medicine.

[15]  Grace Parraga,et al.  Is ventilation heterogeneity related to asthma control? , 2016, European Respiratory Journal.

[16]  John P Mugler,et al.  Clinical correlates of lung ventilation defects in asthmatic children. , 2016, The Journal of allergy and clinical immunology.

[17]  L. Boulet,et al.  Effects of Bronchial Thermoplasty on Airway Smooth Muscle and Collagen Deposition in Asthma. , 2015, Annals of the American Thoracic Society.

[18]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[19]  E. Bateman,et al.  Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. , 2015, The Lancet. Respiratory medicine.

[20]  Jim Kozlowski,et al.  Regional ventilation changes in severe asthma after bronchial thermoplasty with (3)He MR imaging and CT. , 2015, Radiology.

[21]  P. Chanez,et al.  Reduction of airway smooth muscle mass by bronchial thermoplasty in patients with severe asthma. , 2014, American journal of respiratory and critical care medicine.

[22]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[23]  Miranda Kirby,et al.  Hyperpolarized 3He and 129Xe MRI: Differences in asthma before bronchodilation , 2013, Journal of magnetic resonance imaging : JMRI.

[24]  Miranda Kirby,et al.  What are ventilation defects in asthma? , 2013, Thorax.

[25]  I. Pavord,et al.  Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma. , 2013, The Journal of allergy and clinical immunology.

[26]  Jan Wolber,et al.  Quantitative analysis of hyperpolarized 129Xe ventilation imaging in healthy volunteers and subjects with chronic obstructive pulmonary disease , 2013, NMR in biomedicine.

[27]  Stanley J Kruger,et al.  Exercise-induced bronchoconstriction: reproducibility of hyperpolarized 3He MR imaging. , 2013, Radiology.

[28]  J. Gee,et al.  Ventilation‐based segmentation of the lungs using hyperpolarized 3He MRI , 2011, Journal of magnetic resonance imaging : JMRI.

[29]  Arno Klein,et al.  A reproducible evaluation of ANTs similarity metric performance in brain image registration , 2011, NeuroImage.

[30]  Eduard E de Lange,et al.  Demonstration of the heterogeneous distribution of asthma in the lungs using CT and hyperpolarized helium‐3 MRI , 2010, Journal of magnetic resonance imaging : JMRI.

[31]  Brian B. Avants,et al.  N4ITK: Improved N3 Bias Correction , 2010, IEEE Transactions on Medical Imaging.

[32]  Mario Castro,et al.  Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. , 2010, American journal of respiratory and critical care medicine.

[33]  Mark Kosinski,et al.  The minimally important difference of the Asthma Control Test. , 2009, The Journal of allergy and clinical immunology.

[34]  Ana Sousa,et al.  Mepolizumab and exacerbations of refractory eosinophilic asthma. , 2009, The New England journal of medicine.

[35]  J. Mugler,et al.  Changes in regional airflow obstruction over time in the lungs of patients with asthma: evaluation with 3He MR imaging. , 2009, Radiology.

[36]  H. Fox,et al.  Improvement in quality of life with omalizumab in patients with severe allergic asthma , 2006, Current medical research and opinion.

[37]  G H Guyatt,et al.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire. , 1994, Journal of clinical epidemiology.